FormulaFolio Investments’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,065
Closed -$230K 381
2019
Q3
$230K Sell
4,065
-122
-3% -$7.02K 0.01% 310
2019
Q2
$252K Sell
4,187
-380
-8% -$23.3K 0.01% 289
2019
Q1
$298K Sell
4,567
-483
-10% -$31.7K 0.01% 268
2018
Q4
$371K Hold
5,050
0.02% 238
2018
Q3
$371K Sell
5,050
-1,065
-17% -$76.4K 0.02% 239
2018
Q2
$411K Sell
6,115
-574
-9% -$36.9K 0.02% 218
2018
Q1
$417K Buy
6,689
+65
+1% +$4.28K 0.02% 193
2017
Q4
$425K Sell
6,624
-953
-13% -$61.1K 0.03% 182
2017
Q3
$495K Buy
7,577
+188
+3% +$11.9K 0.04% 142
2017
Q2
$464K Sell
7,389
-84
-1% -$5.04K 0.04% 134
2017
Q1
$439K Buy
7,473
+1
+0% +$58 0.05% 121
2016
Q4
$419K Sell
7,472
-418
-5% -$24.1K 0.06% 112
2016
Q3
$486K Sell
7,890
-3,306
-30% -$216K 0.07% 78
2016
Q2
$709K Sell
11,196
-707
-6% -$44.5K 0.12% 61
2016
Q1
$715K Buy
11,903
+1,850
+18% +$113K 0.12% 63
2015
Q4
$703K Buy
+10,053
New +$713K 0.18% 48

Other funds holding PJP

FormulaFolio Investments's PJP Position: Q4 2019 in Review

FormulaFolio Investments sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2019, closing a stake of 4,065 shares — an estimated $230K sold.

FormulaFolio Investments first reported a position in PJP in Q4 2015 and held it in 16 quarters. The position peaked at $715K in Q1 2016. 93 funds tracked by Wall St. Rank hold PJP as of Q4 2019.

  • FormulaFolio Investments reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2019 after selling out during the quarter.
  • FormulaFolio Investments sold 4,065 Invesco Pharmaceuticals ETF shares in Q4 2019, an estimated $230K.
  • FormulaFolio Investments first reported a position in Invesco Pharmaceuticals ETF in Q4 2015 and held it in 16 quarters.
  • FormulaFolio Investments's Invesco Pharmaceuticals ETF position peaked at $715K in Q1 2016.
  • 93 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2019.

Based on FormulaFolio Investments's 13F filing for Q4 2019, filed 15 Jan 2020.